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A B S T R A C T   
The aim of this study was to evaluate the behavior of different lipid-based nanostructures during in vitro 
digestion, in particular on curcumin’s bioaccessibility, and to access their potential toxicity. Solid lipid nano-
particles (SLN), nanostructured lipid carriers (NLC) and nanoemulsions (NE) were submitted to harmonized 
static in vitro digestion and their cytotoxicity and cellular transport were evaluated using Caco-2 cell line. 
NE presented the highest curcumin’s bioaccessibility followed by NLC and SLN, 71.1%, 63.7% and 53.3%, 
respectively. Free fatty acids percentage increased in the following order: NLC ≤ NE < SLN. Non-digested 
nanostructures and excipients presented no cytotoxicity; however, digested NE and NLC presented cytotox-
icity due to MCT oil, which presented cytotoxicity after digestion. The apparent permeability coefficient of NLC 
was higher than SLN and NE. 
These results showed that lipid-based nanostructures’ physical state and composition have a high influence on 
particles’ behavior during digestion, and on their cytotoxicity/intestinal permeability, and highlights the 
importance of conducting cytotoxicity assessments after in vitro digestion. 
This work contributes to a better understanding of the behavior of lipid-based nanostructures under digestion/ 
adsorption, and this knowledge will be useful in design of nanostructures that afford both safety and an increased 
bioactive compounds’ bioavailability.   
1. Introduction 
Curcumin is a lipophilic polyphenolic compound derived from 
turmeric (Curcuma longa), widely known by its broad range of health- 
promoting functions, including anti-inflammatory, anticarcinogenic, 
antimicrobial and antioxidant activities (Chang et al., 2019; Perrone 
et al., 2015). Therefore, it is catching considerable attention from food 
scientists due to its potential use as a natural antioxidant and antimi-
crobial on beverages and functional foods (Tang, 2020). However, 
despite the established curcumin beneficial effects, its applications in 
food products are hindered by its poor solubility and quick degradation 
on aqueous solution (Gómez-Estaca, Balaguer, López-Carballo, Gavara, 
& Hernández-Muñoz, 2017). In addition, its poor absorption, high 
chemical instability, metabolic degradation during physiological transit, 
metabolic end-products inactivity, accumulation within epithelial in-
testine cells and its rapid elimination from the body results in a very low 
bioavailability (Faralli, Shekarforoush, Ajalloueian, Mendes, & Chron-
akis, 2019). 
In order to overcome these major drawbacks, different strategies 
have been undertaken to enhance curcumin solubility, stability and 
cellular permeability and consequently, improve its bioavailability. One 
of the most commonly used strategies is the encapsulation of curcumin 
on different nanostructured delivery systems. Particularly, it has been 
shown that different lipid-based nanostructures can be appropriate 
templates to encapsulate curcumin and improve its stability and 
bioavailability upon digestion (Nayak, Mills, & Norton, 2016). Nano-
emulsions (NE), defined as thermodynamically unstable small particles 
(radius < 100 nm) comprising two immiscible liquids (with one of the 
liquids being dispersed in the other one), are particularly useful for this 
purpose. In fact, NE show significant advantages compared to macro-
emulsions, including increased transparency, high surface area (leading 
to a higher absorption), physical stability (to gravitational separation, 
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flocculation and coalescence) and bioavailability (McClements, 2012). 
However, some NE limitations have been described namely, instability 
(e.g. Oswald ripening, creaming, flocculation, and coalescence) and the 
use of large amounts of surfactants to stabilize them (McClements, 
2012). To overcome these limitations, more advanced lipid carriers, 
such as solid lipid nanoparticles (SLN) and nanostructured lipid carries 
(NLC) have been developed. SLN and NLC are formed by solid lipids 
formulated to improve bioactive compounds’ stability, bioavailability 
and to modulate their release rate (Pimentel-Moral et al., 2018). SLN are 
characterized by the presence of a mixture of one or more solid lipids, 
being the bioactive compounds entrapped within the solid matrix, 
whereas, NLC are composed by a solid and liquid lipid mixture (Souto & 
Doktorovová, 2009). 
Although nanostructured delivery systems use has been reported as a 
promising technique to improve curcumin bioavailability as well as its 
physical and chemical stability, the use of sub-micro particles is raising 
safety concerns among consumers, regulatory agencies and food in-
dustry. In fact, depending on their composition, structure and proper-
ties, ingested nanostructured delivery systems may cause toxicity due to 
different mechanisms, such as i) interference with normal gastrointes-
tinal functions, ii) accumulation within specific tissues; iii) cytotoxicity 
and cellular malfunction; iv) modification of bioactive compounds’ 
release location; and v) interference with gut microbiota (McClements & 
Xiao, 2017). Therefore, the evaluation of nanostructured delivery sys-
tems behavior once ingested will allow to optimize delivery systems’ 
design (i.e. maximize curcumin intestinal absorption and therefore, its 
health benefits) and to assess their safety. 
During the digestion process, the physical state of lipid-based 
nanostructures, among other characteristics, may influence some enzy-
matic and physicochemical processes, such as, droplet coalescence and 
disruption, interfacial composition, lipid digestibility and micelle solu-
bilization, and consequently, the curcumin’s bioavailability. In this 
context, three lipid-based nanostructures - NE, SLN and NLC - formu-
lated with carrier oil at different physical states (i.e. liquid, solid and 
liquid/solid mixture, respectively) have been tested as strategies to 
enhance curcumin’s bioavailability. These lipid-based nanostructures 
have been submitted to an in vitro harmonized static digestion, where 
their behavior has been evaluated in terms of lipid digestibility, curcu-
min’s bioaccessibility, stability and effective bioavailability. Further-
more, the cytotoxicity of lipid-based nanostructures and their excipients 
were assessed before and after digestion protocol using Caco-2 cell line 
as well as the cellular permeability. Such a complete study on the 
behavior of different lipid-based nanostructures under digestion and 
absorption has not been performed before. 
2. Materials and methods 
2.1. Materials 
Beeswax produced by Apis mellifera was purchased from QUIMIND 
(Porto, Portugal), PHOSPHOLIPON® 90G, composed by 90% of phos-
phatidylcholine from soybean, and PHOSPHOLIPON® 80H, composed 
by hydrogenated phospholipids from soybean with 70% phosphatidyl-
choline, were kindly provided by Lipoid (Switzerland). Neobee 1053 
Medium Chain Triglycerides (MCTs) composed by caprylic/capric tri-
glyceride oil with a fatty acid distribution of 55% C8:0 and 44% C10:0, 
was kindly provided by Stepan (The Netherlands). Curcumin, pepsin 
from porcine gastric mucosa (≥2500 U.mg− 1), bile extract porcine, 
pancreatin from porcine pancreas (8x USP), Pefabloc® SC, salts used to 
prepare oral, gastric and intestinal electrolyte solutions, Nile red and 
dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich (MO, 
USA). Tween® 80 was obtained from Panreac (Spain), sodium hydrox-
ide was purchased from JMGS (Portugal) and hydrochloric acid was 
obtained from CHEM-LAB (Belgium). Acetonitrile and chloroform were 
obtained from Fisher Scientific (NJ, USA). Dulbecco’s modified Eagle’s 
medium (DMEM), non-essential amino acids (NEAA), phosphate 
buffered saline (PBS), Hanks’ Balanced Salt Solution (HBSS) were ob-
tained from Lonza (Switzerland), penicillin/streptomycin (P/S) were 
purchased from Sigma-Aldrich (MO, USA), fetal bovine serum (FBS) was 
obtained from Merck (Germany), trypsin/EDTA was purchased from 
Invitrogen (Paisley, UK) and 3-(4,5-dimethylthiazol-2-yl)-5(3-carbox-
ymethonyphenol)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) were ob-
tained from Promega (Madison, EUA). Tissue culture plate inserts (12 
wells, 0.4 μm pore size, polycarbonate membrane, 1.12 cm2) were 
purchase from VWR Collection (VWR International, Portugal). Caco-2 
cell line was purchased from Deutsche Sammlung von Microorganis-
men und Zellkulturen (Braunschweig, Germany). 
2.2. SLN production 
SLN were prepared according to Kheradmandnia, Vasheghani- 
farahani, Nosrati, and Atyabi (2010) with some modifications. 
Different formulations have been tested (Table 1, Supplementary File) 
and the formulation used was selected based on the results of the 
droplet’s size, PDI and stability (results not shown). Beeswax (3%), 
PHOSPHOLIPON® 90G (lecithin) (1.5%) and curcumin (0.1%) were 
melted on a water bath at 80 ◦C. Tween® 80 (1.5%) was solubilized in 
distilled water at 80 ◦C in an Ultra-Turrax homogenizer (T18, Ika-Werke, 
Germany) during 2 min at 3,400 rpm. The aqueous solution was added 
to the lipid solution and mixed on an Ultra-Turrax homogenizer (T18, 
Ika-Werke, Germany) at 18,000 rpm during 8 min. Then, the resulting 
nanoemulsion was gradually dispersed at a volume ratio of 1:10 in cold 
water at 2 ◦C under stirring at 2,000 rpm. The SLN solution was stored at 
4 ◦C under dark conditions. 
2.3. NLC production 
NLC were produced through high-speed homogenization and ultra-
sonication as reported by Aditya et al. (2013), with some modifications. 
Different formulations have been tested (Table 1, Supplementary File) 
and the formulation used was selected based on the results of the 
droplet’s size, PDI and stability (results not shown). Lipid phase, formed 
by curcumin (0.1%), PHOSPHOLIPON® 90G (lecithin) (1.5%), MCTs 
(2.5%) and beeswax (2.5%), was melted at 75 ◦C. Tween® 80 (1.5%) 
and distilled water were heated to 75 ◦C forming the aqueous phase. 
Then aqueous phase was quickly dispersed in the lipid phase. Both 
phases were homogenized using an Ultra-Turrax homogenizer (T18, Ika- 
Werke, Germany) during 5 min at 3,000 rpm. The resulting emulsion 
was subject to ultrasonication through a probe sonicator (Vibra-cell VCX 
500, Sonics, USA) for 4 min (work time: 4 s; rest time: 2 s). Finally, it was 
dispersed in cold water at 2 ◦C at a volume ratio of 1:10 under stirring at 
600 rpm for 15 min. The NLC solution was stored at 4 ◦C under dark 
conditions. 
2.4. NE production 
NE were prepared through high pressure homogenization according 
to other authors (Pinheiro, Coimbra, & Vicente, 2016). Different for-
mulations have been tested (Table 1, Supplementary File) and the 
formulation used was selected based on the results of the droplet’s size, 
PDI and stability (results not shown). The lipid phase was composed by 
MCTs and curcumin (0.1%) and the aqueous phase by PHOSPHOLI-
PON® 80H (lecithin) (2.5%) and distilled water. Both phases were ho-
mogenized at a volume ratio of 1:9 at room temperature. First, both 
solutions were pre-mixed using an Ultra-Turrax homogenizer (T18, Ika- 
Werke, Germany) during 2 min and thereafter, the resulting emulsion 
was passed through a high-pressure homogenizer (NanoDeBee, Bee In-
ternational, Massachusetts, USA) at 20,000 psi (137.9 MPa) during 20 
cycles. The NE solution was stored at 4 ◦C under dark conditions. 
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2.5. In vitro digestion 
All nanostructures were subjected to an in vitro digestion process 
using the harmonized static in vitro digestion model described by 
Minekus et al. (2014). This model simulates the mouth, stomach and 
intestinal phases. In the oral phase, simulated salivary fluid (SSF) (KCl 
15.1 mM, KH2PO4 3.7 mM, NaHCO3 13.6 mM, MgCl2(H2O)6 0.15 mM, 
(NH4)2CO3 0.06 mM and HCl 1.1 mM), CaCl2(H2O)2 0.3 M (in order to 
achieve 0.75 mM at the final mixture) and Milli-Q water (in order to 
make up the final volume) were added to 5 mL of sample. The mixture 
was incubated at 37 ◦C for 2 min under orbital agitation at 120 rpm. 
α-amylase was not used as samples did not contain starch (Sarkar, Goh, 
& Singh, 2009). In gastric phase, simulated gastric fluid (SGF) (KCl 6.9 
mM, KH2PO4 0.9 mM, NaHCO3 25 mM, NaCl 47.2 mM, MgCl2(H2O)6 
0.12 mM, (NH4)2CO3 0.5 mM and HCl 15.6 mM), CaCl2(H2O)2 0.3 M (in 
order to achieve 0.075 mM at the final mixture) and pepsin solution 
(with final activity of 2,000 U/mL in the final mixture) were added to 
the previous mixture. The pH was adjusted to 3.0 with HCl 1 M and 
Milli-Q water was added to make up the final volume. The samples were 
incubated for 2 h at 37 ◦C under orbital agitation at 120 rpm. Finally, the 
intestinal phase consisted of simulated intestinal fluid (SIF) (KCl 6.8 
mM, KH2PO4 0.8 mM, NaHCO3 85 mM, NaCl 38.4 mM, MgCl2(H2O)6 
0.33 mM and HCl 8.4 mM), CaCl2(H2O)2 0.3 M (in order to achieve 0.3 
mM at the final mixture), bile salts (in order to achieve 10 mM at the 
final mixture) and pancreatin solution (with final activity of 100 U/mL 
in the final mixture). The pH was adjusted to 7.0 with NaOH 1 M or HCl 
1 M and then Milli-Q water was added to achieve the final volume. The 
samples were incubated during 2 h at 37 ◦C under orbital agitation at 
120 rpm. After each phase, samples were collected. For microscopy 
analysis, the gastric phase reaction (i.e. pepsin activity) was stopped by 
increasing the pH to 7.0 using NaOH 1 M and placing the samples in an 
ice bath, while for particle’s size analysis, which was carried out 
immediately after gastric phase, the samples were placed in an ice bath. 
After full digestion, the reaction was stopped adding enzyme inhibitor 
Pefabloc® (1 mM) (10 µL for each 1 mL of sample). All the samples were 
tested at least in triplicate. 
2.6. Nanostructures’ particle size and ζ-potential 
Nanostructures’ particle size, polydispersity index (PDI) and ζ-po-
tential were measured in each digestion process phase using dynamic 
light scattering (DLS) (Zetasizer Nano SZ, Malvern, Worcestershire, UK). 
All samples were diluted at 1:100 with a buffer solution of the same pH 
of the samples. 
2.7. Curcumin’s bioaccessibility and stability 
Curcumin bioaccessibility was assumed as the curcumin fraction 
present inside the micelle phase, while stability was assumed as the non- 
transformed curcumin fraction present in the whole digesta at the end of 
the digestion. Curcumin bioaccessibility and stability have been deter-
mined at the end of the digestion based on the methodology described by 
Liu, Wang, McClements, and Zou (2018) with some modifications. The 
digesta (10 mL) was centrifuged (Allegra 64R, Beckman Coulter Inc., 
USA) at 18,700 g at room temperature for 30 min, and the supernatant 
(which was assumed as the micelle phase) was collected. Digesta or 
micelle phase samples (5 mL) were mixed with 5 mL of chloroform using 
a vortex and centrifuged at 700 g at room temperature for 10 min. The 
bottom layer was collected, and the top layer was subjected again to the 
extraction procedure. The second bottom layer was combined with the 
first one and analyzed in an UV–VIS spectrophotometer (V-560, Jasco, 
USA) at 420 nm. Curcumin concentration was determined through a 
calibration curve (absorbance versus curcumin concentration) in 
chloroform. 
Curcumin bioaccessibility (B), stability (S) and effective bioavail-
ability (BA) were calculated using Eqs. (1)–(3) (respectively) (Liu et al., 








× 100 (2)  
BA = B × S (3)  
where Cmicelle and CDigesta are the curcumin concentrations measured at 
the end of the digestion in micellar phase and digesta, respectively. 
Cinitial is the curcumin concentration present in the nanostructures at the 
beginning of digestion process, which is the same for all nanostructures. 
The effective bioavailability is a curcumin absorption estimative; how-
ever, this value must be analyzed with precaution, once there are other 
factors that influence curcumin absorption which were not considered, 
such as absorption and metabolism (Zou et al., 2016). 
2.8. Free fatty acids release 
Free fatty acids (FFA) release was the method used to measure 
nanostructures’ digestibility. At the end of the gastric phase, the sample 
was mixed with all salt’s solutions of the intestinal phase (Section 2.5) 
and the pH was adjusted to 7.0 with HCl 1 M or NaOH 1 M. Then, 
pancreatin solution was added to the sample and pH was maintained at 
7.0 by the addition of 0.05 M NaOH solution using an auto-titration unit 
(pH-stat method) (Titrando 902, Metrohm, Switzerland) during 2 h in a 
heated jacketed reactor at 37 ◦C under agitation. Blank assays have been 
performed (i.e., digestion conducted without pancreatin) to determine 
the NaOH volume needed to achieve pH 7.0. The FFA released amount, 




(VNaOH Sample − VNaOH Blank) × mNaOH × Mlipid
wlipid × 2
)
× 100 (4)  
where VNaOH sample and VNaOH Blank are the NaOH titrated volume in the 
sample and blank assays, respectively, mNaOH is the NaOH titrant molar 
concentration, in this case 0.05 M, Mlipid is the molecular weight of MCT 
oil (500 g.mol− 1) and the beeswax’s reference lipid (256.4 g.mol− 1 for 
palmitic acid) and wlipid is the initial mass of lipid (g). 
2.9. Fluorescence microscopy 
Nanostructures’ microstructure was observed using a fluorescence 
microscope (Olympus, BX51, Japan). The samples were stained with 
Nile Red (0.25 mg/mL in DMSO) at 1:10 ratio (dye:sample, v/v), which 
enabled the oil droplets to become visible. Samples of the initial nano-
structures and of each digestion process phase were analyzed. The im-
ages were captured with a 100x oil immersion objective lens. 
2.10. Cell culture and digested samples treatment 
Caco-2 cell line was used for cytotoxicity and permeability studies. 
Caco-2 cells were grown in DMEM supplemented with 10% (v/v) FBS, 
1% (v/v) NEAA solution and 1% (v/v) P/S. Cell cultures were grown in a 
humidified 5% CO2 incubator at 37 ◦C and medium was changed 
periodically. 
In order to eliminate precipitates and residues resulting from the 
digestive process, digested samples used on cellular assays were sub-
jected to a filtration and centrifugation process. The mixture was 
transferred to Amicon® Ultra-4 Centrifugal Filter, 10 KDa (Merck Mil-
lipore, Germany) and centrifuged (Mikro 220R, Hettich, Germany) at 
4,000g for 40 min. The filtrated samples were used on subsequent 
cellular assays. 
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2.11. Cell viability assay 
Viability assays were performed using Caco-2 cells. Cells were seeded 
in 96-well culture plates at 2 × 104 cells/well, and the medium changed 
every 48 h. The cells were allowed to grow for 5–7 d, until confluence 
was reached. All samples tested were diluted in DMEM culture medium 
with 0.5% FBS (Serra et al., 2011). The digested and non-digested 
nanostructures’ dilutions were defined regarding the maximum curcu-
min’s concentration present in the samples. The digested and non- 
digested excipients were diluted with regard to the maximum excip-
ient concentration present in the nanostructures. Finally, gastrointes-
tinal (GI) fluids sample was diluted with regard to the maximum 
curcumin concentration in non-digested nanostructures. All diluted 
samples were added to the wells, except the control cells wells which 
contained only the solvent/medium used. The incubation with the 
different formulations was carried out for 24 h in a 5% CO2 humidified 
atmosphere at 37 ◦C. The experiments were conducted in triplicate with 
cells between passages 40 and 45. 
Viability evaluation was performed by the colorimetric MTS assay. 
This assay is based on the conversion of tetrazolium salt, into a colored 
formazan product, by mitochondrial activity of viable cells at 37 ◦C. The 
viability reagent was diluted according to the manufacturer informa-
tion, 16% (v/v) of MTS in cell culture media (DMEM supplemented with 
0.5% FBS). Following the incubation period (24 h at 37 ◦C in a 5% CO2 
humidified atmosphere) samples were removed, cells were rinsed with 
PBS and 100 μL MTS was added to each well, reacting for 3 h at 37 ◦C in 
a 5% CO2 humidified atmosphere. The quantity of formazan produced 
was measured in a spectrophotometer (EPOCH, 219 Bio-Tek, USA) at 
490 nm and is directly proportional to the number of living cells in 
culture. The results were expressed as percentage (%) of cell viability 
relative to the control (i.e. untreated cells in DMEM medium). The plates 
were also examined under the microscope to assess the degree of cell 
survival (Serra et al., 2011). 
2.12. Curcumin permeability studies 
Curcumin permeability studies were carried out based on Silva et al. 
(2019), with some modifications. Caco-2 cells were cultured at 1x105 
cells/well on 12-well cell culture plate inserts for 18–21 d. The culture 
medium was changed three times a week. The cell monolayer’s devel-
opment and integrity were controlled two to three times a week by the 
transepithelial electrical resistance (TEER) measurements using an 
epithelial Volt-Ohm-meter (Millipore Millicell ERS-2, Massachusetts, 
USA). On the day of the experiment, the culture medium was removed; 
the cells were washed twice with 200 μL of HBSS and incubated during 
15 min at 37 ◦C in 5% CO2 with 200 μL HBSS solution (transporter 
buffer). For the permeability experiment, 0.5 mL of nanostructures (i.e. 
SLN, NLC and NE) or free curcumin diluted with HBSS at 25 µg.mL− 1 of 
curcumin were added to the apical side. In order to maintain well con-
ditions, 1.5 mL of HBSS with 1% of Tween® 80 was added to the 
basolateral side (Silva et al., 2017). At defined times (0, 15, 30, 45, 60, 
120, 180 and 240 min), basolateral samples were collected. All samples 
were frozen until curcumin’s determination through HPLC-FL as 
described in Section 2.13 (Silva et al., 2019). 
The apparent permeability coefficients (Papp) of curcumin were 






where dQ/dt is the cumulative transport rate (μg.min− 1) across the 
monolayer established as the slope obtained by the linear regression of 
cumulative transported amount as a function of time, C0 is the initial 
curcumin concentration (μg.mL− 1) in the apical compartment and A is 
the surface area of the membrane (1.12 cm2). 
2.13. HPLC analysis of curcumin 
The curcumin concentration was determined based on the method-
ology described by Silva et al. (2019). The samples were diluted in 
acetonitrile at a volume ratio of 1:1 and centrifuged during 15 min at 
14,000 rpm. After that, the supernatant was collected and injected in the 
HPLC system. The HPLC system was composed by a Varian Prostar 210 
pump, a Varian Prostar 410 autosampler and a Jasco FP-920 fluores-
cence detector (λexc = 420 nm and λem = 540 nm). A Varian 850-MIB 
data system interface and a Galaxie chromatography data system were 
used to manage the instrument and the chromatographic data, respec-
tively. The HPLC separation was carried out on a C18 reverse-phase 
YMC-Pack ODS-AQ analytical column (250 × 4.6 mm I.D., 5 μm), 
which was fitted with a pre-column with the same stationary phase. The 
mobile phase consisted in a mixture of aqueous acetic acid (2% v/v) at 
pH 2.5 and acetonitrile at a volume ratio of 47:53, which was filtered 
and degassed with a 0.22 μm nylon membrane filter (GHP, Gelman). The 
compounds were eluted at a flow rate of 1.0 mL.min− 1 during a 15 min 
isocratic run at 25 ◦C and the injection volume was 50 μL. The cali-
bration curve was performed using standard solutions with concentra-
tions between 0.1 μg.mL− 1 and 10 μg.mL− 1 of curcumin (Sigma-Aldrich 
(MO, USA)) in acetonitrile. The retention times of bisdemethox-
ycurcumin, demethoxycurcumin and curcumin, were 10 min, 11 min 
and 12 min, respectively. Their quantification was performed through 
the comparison between the peak’s areas obtained and the calibration 
curve. 
2.14. Statistical analyses 
The assays were performed at least in triplicate and presented as 
mean ± standard deviation (SD). Statistical analysis was carried out 
using OriginPro 2018 Statistic software (version b9.5.1.195; OriginLab 
Corporation, Northampton, USA). Data were analyzed using one-way 
analysis of variance (ANOVA) and Tukey’s test was used to evaluate 
significant differences between the mean values (p < 0.05). 
3. Results and discussion 
3.1. Nanostructures’ characterization 
The nanostructures were produced with different techniques, namely 
NE were produced by high pressure homogenization, NLC by high speed 
homogenization and ultrasonication and SLN by high speed homoge-
nization. All ingredients used to produce all nanostructures were bio- 
based and/or GRAS. 
The particle size, PDI and ζ-potential of all nanostructures are pre-
sented in Table 1. NE and SLN presented similar particle sizes (between 
140 nm and 150 nm), while NLC’ size was significantly higher (p <
0.05), 164.4 ± 10.27 nm, showing that the lipid physical state (liquid vs 
solid) had no significant effect on particle size. However, for NLC, the 
liquid lipid proportion in the liquid/solid mixture could have a high 
influence in this parameter. Similarly, de Souza, Saez, de Campos, and 
Mansur (2019) showed that when MCT proportion was reduced from 
three to two parts per one part of solid lipid, the NLC produced presented 
an increase of particle’s size. Furthermore, other authors reported that 
Table 1 
Particle size, polydispersity index (PDI) and ζ-potential of curcumin loaded NE, 
NLC and SLN.  
Structure z-average diameter (nm) PDI ζ-Potential (mV) 
NE 146.0 ± 8.8a 0.233 ± 0.023a − 32.5 ± 2.0a 
SLN 145.4 ± 8.1a 0.253 ± 0.010b − 23.6 ± 1.3b 
NLC 164.4 ± 10.6b 0.108 ± 0.015c − 11.2 ± 1.3c 
XXXa-c Mean values with different superscript letters within the same column are 
significantly different from each other (p < 0.05). 
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the incorporation of liquid oil in the production of NLC can increase the 
particle size due to interfacial tension increase, nanoparticles swollen 
core increase or core-shell type nanoparticles production (Tamjidi, 
Shahedi, Varshosaz, & Nasirpour, 2014). 
According to the results, all nanostructures showed PDI values lower 
than 0.3 and particle size below 200 nm, being suitable for oral delivery 
(Swarnakar, Venkatesan, & Betageri, 2019). NLC presented the lowest 
PDI value comparing to NE and SLN (0.108, 0.233 and 0.253, respec-
tively) (p < 0.05). However, all nanostructures showed a narrow dis-
tribution size (PDI < 0.3), (Table 1). These differences were probably 
caused by the technique used to produce each type of nanostructure, 
showing that high-speed homogenization produce samples with higher 
PDI values than ultrasonication processes. de Souza et al. (2019) tested 
different types of techniques to produce NLC and showed that the 
nanoparticles produced using high-speed homogenization presented 
higher PDI values than those produced using ultrasonication. Together 
with the technique used, the emulsifier composition and their concen-
tration could also have influence on the particle’s size and PDI of the 
nanostructures, as observed by other authors (El Kinawy, Petersen, 
Bergt, & Ulrich, 2013; Ma et al., 2018). 
Regarding ζ-potential, it is possible to observe that all nanostructures 
presented negative values, with NE showing the lowest negative value 
and NLC the highest one: − 32.5 mV and − 11.2 mV, respectively 
(Table 1). Usually, a nanosuspension is considered physically stable 
when the ζ-potential value is around ±30 mV and stabilized only by 
electrostatic repulsion. However, when a combined electrostatic and 
steric stabilization exists, it is required a lower ζ-potential, around ±20 
mV (Tamjidi et al., 2014). In case of SLN and NLC, their stabilization is a 
combination of electrostatic forces due to the presence of lecithin and 
steric-related forces due to Tween® 80. Other authors also reported SLN 
and NLC ζ-potential values <− 20 mV, using lecithin and Tween® 80 as 
emulsifiers (Soleimanian, Goli, Varshosaz, & Sahafi, 2018). Further-
more, the difference of ζ-potential between SLN and NLC can be due to 
the ratio of lipids and emulsifiers’ concentration. Despite both nano-
structures have the same emulsifier composition and concentration, SLN 
has a lower lipids’ concentration than NLC. Thus, SLN has more emul-
sifier to cover the lipid droplets, which resulted in an increase of the 
ζ-potential negative value. 
3.2. In vitro digestion 
3.2.1. Size, ζ-potential and morphology 
Particle size and ζ-potential have been determined throughout the 
digestion process. Fig. 1 presents the ζ-potential of curcumin-loaded 
nanostructures (i.e. NE, SLN and NLC) (Fig. 1A) and their z-average 
diameter (Fig. 1B) before digestion (initial) and after each simulated 
digestion process phase (namely, oral, gastric and intestinal phases). As 
discussed previously, before digestion, NE, SLN and NLC showed nega-
tive ζ-potential values. When the nanostructures were subjected to the 
simulated oral conditions, NE maintained their surface charge, while 
SLN and NLC showed a slight, but significant (p < 0.05), decrease of 
ζ-potential values. This could be due to the electrostatic screening effects 
between lipid particles and salt ions present in the simulated salivary 
fluid (Chang & McClements, 2016). Under simulated gastric conditions, 
all nanostructures presented a positive surface charge, ranging between 
13.2 ± 0.60 mV and 4.2 ± 0.56 mV, where NE had the highest ζ-po-
tential value (p < 0.05). The high ionic strength, low pH and ionic 
species present in the gastric phase can promote changes in the inter-
facial surface of lipid particles. However, when the nanostructures pass 
to the intestinal phase, ζ-potential values were negative and close to the 
initial ζ-potential values. This may be due to the neutral pH found in this 
phase, the adsorption of lipase and anionic species (i.e. phospholipids 
and bile salts present in the simulated intestinal fluid) to the nano-
structures’ surface and fatty acids production by lipid digestion (Park, 
Garcia, Shin, & Kim, 2017). 
During in vitro digestion, it seems that all nanostructures are stable at 
the oral phase; however, at the end of the gastric phase, they showed 
some instability (p < 0.05), where NE showed the highest particle size 
increase from 125.5 ± 14.17 nm to 1605.7 ± 164.4 nm (p < 0.05) 
(Fig. 1B). In fact, the NE fluorescent images showed that some coales-
cence had occurred during the gastric phase (Fig. 2). The changes at 
lipid droplets’ interfacial surface (showed by ζ-potential results) could 
have decreased the repulsion between lipid droplets and promoted ag-
gregation through coalescence, resulting in a size increase. Ozturk, 
Argin, Ozilgen, and McClements (2014) also showed that lecithin NE 
exhibited some instability when subjected to high ionic strength and low 
pH. Similarly, other authors demonstrated that lecithin NE particle size 
increased after the gastric phase (Chang & McClements, 2016; Shu et al., 
2018). Regarding SLN and NLC, both presented a particle size increase 
(p > 0.05) after the gastric phase from 145.3 ± 4.64 nm to 489.1 ±
215.11 nm and from 173.3 ± 7.52 nm to 524.5 ± 168.2 nm, respec-
tively. These results may be explained by destabilization of forces 
exerted on the lipid particles due to the presence of lecithin and Tween® 
80. The electrostatic force is annulled due to the low pH and high ionic 
strength, while the steric force is not strong enough to maintain the 
repulsion between particles, causing some aggregation as can be seen on 
Fig. 2 (Zimmermann & Müller, 2001). After 2 h of intestinal phase, all 
nanostructures presented a slight particle size increase, but not signifi-
cant (p > 0.05). NE presented a higher particle size increase than SLN 
and NLC during in vitro digestion process. Thus, nanostructures 
composed only by liquid lipids (e.g. NE) seems to be more unstable 
under digestion than the nanostructures which have solid lipids in their 
Fig. 1. ζ-potential (A) and particle size (B) of nanostructures (NE, SLN and NLC) in different in vitro gastrointestinal digestion phases. Error bars represent the 
standard deviation of n = 3 replicates. A-CDifferent capital letters indicate significant difference between simulated gastrointestinal phases. a-gDifferent lower-case 
letters indicate significant difference between nanostructures/phase interactions (p < 0.05). 
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lipid phase composition. Also, the nanostructures’ emulsifier composi-
tion (lecithin for NE and lecithin + Tween 80® for NLC and SLN) could 
have influenced their behavior under digestion. 
3.2.2. FFA release 
During in vitro intestinal phase digestion, all nanostructures 
presented a fast FFA’s concentration increase (a burst release) on the 
first minutes and then a more gradual concentration increase on the 
remaining time (data not shown). At the end of in vitro digestion, NE 
presented a lower FFA percentage than SLN, 40.7 ± 2.98%, 53.4 ±
2.44%, respectively (p < 0.05), Fig. 3. Although liquid particles’ (i.e. 
NE) surface promotes an easier access and better bile and lipase 
Fig. 2. Fluorescence microscopy images of nanostructures (SLN, NLC and NE) after each in vitro gastrointestinal digestion phase. The scale bar for all images is 
10 μm. 
Fig. 3. Percentage of FFA released after in vitro digestion from curcumin-loaded SLN, NLC and NE. Error bars represent the standard deviation of n = 3 replications. 
Different letters indicates significant difference between nanostructures (p < 0.05). 
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adsorption than solid particle surface (i.e. SLN), promoting a higher 
lipolysis rate and degree (Bonnaire et al., 2008), the particle’s size 
instability observed in NE at the end of the gastric phase, may explain 
these results, once the increase of the particle’s size reduces the surface 
area for lipase adsorption reducing the lipid digestion. NLC presented 
the lowest FFA percentage, 32.8 ± 3.58%, which can indicate that the 
combination of liquid and solid lipids can cause a higher resistance to 
the lipase’s adsorption and hydrolysis. Bonnaire et al. (2008) reported 
that, besides the influence of lipid physical state on lipase adsorption to 
the droplet surface, where typically liquid lipids promote a better li-
pase’s adsorption than the solid lipids, the spatial organization of lipid 
molecules can influence lipase ability to hydrolyze the triacylglycerols, 
once the triglycerides crystals can present different polymorphs, namely 
the β-form which is the densest polymorphic form (Himawan, Starov, & 
Stapley, 2006). Other authors observed that, besides the lipid’s physical 
state, the chain length of the fatty acids in the lipid composition has a 
high impact in the FFA release and therefore in the lipid digestion degree 
(Helena de Abreu-Martins, Artiga-Artigas, Hilsdorf Piccoli, Martín-Bel-
loso, & Salvia-Trujillo, 2020). 
The presented results showed that the lipid digestion degree can be 
affected by the stability of nanostructures under digestion (e.g. particle 
size) as well as the lipid composition and physical state. 
3.2.3. Bioaccessibility, stability and effective bioavailability 
At the end of the in vitro digestion process, nanostructures’ bio-
accessibility and stability were measured and effective bioavailability 
was calculated using the bioaccessibility and stability values. Fig. 4 
depicts the effect of the different nanostructures in curcumin’s bio-
accessibility, stability and consequently, effective bioavailability. 
Generally, NE presented the highest values for all analyzed parameters, 
followed by NLC and SLN (p < 0.05). The curcumin’s stability was 62.8 
± 5.85% for NE, 46.4 ± 3.28% for NLC and 29.3 ± 1.39% for SLN, 
showing that the presence of liquid lipid in the nanostructure’s 
composition promoted curcumin’s protection. The higher curcumin’s 
stability observed in NE can be due to the fact of curcumin remained 
solubilized in the oil phase regardless of the particle stability and lipid 
digestion. Relatively to the lower stability observed in SLN, this can be 
caused by the expulsion of the bioactive compound from the fat crystals, 
increasing their concentration at the surface of the SLN and, therefore, 
the bioactive compound is more susceptible to degradation (Qian, 
Decker, Xiao, & McClements, 2013). Although SLN and NLC are 
proposed to promote the bioactive compound’s stability when compared 
to NE, the bioactive compounds’ stability depends on different factors, 
such as its affinity to the solid lipid, the location where is incorporated in 
the particle and the type of the bonds between the bioactive compound 
and the particle. 
NE also exhibited higher bioaccessibility (71.7 ± 6.18%) than NLC 
and SLN, (63.7 ± 3.58% and 53.3 ± 3.70%, respectively) (p < 0.05). 
These results may be associated to the lipid’s physical state. NE pre-
sented the highest curcumin bioaccessibility, indicating that curcumin 
was effectively incorporated within the mixed micelles formed by FFA 
released, bile salts and phospholipids. On the other hand, curcumin 
bioaccessibility obtained for NLC was higher than the one observed for 
SLN, despite SLN presented higher FFA released than NLC. This can be 
due to fatty acid composition and fat content differences observed in the 
formulations, since NLC have in their composition a liquid oil whose 
digestion products can promote a higher incorporation of curcumin in 
the mixed micelles, increasing its bioaccessibility. SLN presented the 
lowest bioaccessibility probably due to the composition of the mixed 
micelles produced and their solubilization capacity. Helena de Abreu- 
Martins et al. (2020) studied the lipolysis kinetics, micelle fraction 
composition and the β-carotene bioaccessibility of SLN with different 
solid lipids and observed that besides the lipid digestion extent, the 
mixed micelles composition has a high impact on the β-carotene bio-
accessibility. Also, the results from the present work are in accordance 
with other studies that reported that bioactive compounds loaded on 
particles produced with liquid lipids showed higher bioaccessibility than 
particles produced with solid lipids (Aditya et al., 2014). 
3.3. Cellular studies 
The effect of digested and non-digested curcumin-loaded NE, SLN 
and NLC, as well as their excipients (before and after in vitro digestion), 
on cell viability was determined. The range of curcumin concentrations 
selected to perform the viability assays of digested curcumin-loaded 
nanostructures were based on the curcumin concentration detected 
after in vitro digestion assay. All non-digested nanostructures presented 
no cytotoxic effects at the highest curcumin’s concentration tested, 40 
μg.mL− 1 of curcumin (data not shown). Regarding digested nano-
structures, SLN were not cytotoxic to cells at the highest curcumin’s 
concentration tested (i.e. 3.4 μg.mL− 1 curcumin) as can be seen on 
Fig. 5a. However, the cell viability decreased around 2.0 μg.mL− 1 
Fig. 4. Bioaccessibility, stability and effective bioavailability of curcumin loaded in SLN, NE and NLC after in vitro digestion process. Error bars represent the 
standard deviation of n = 6 replications. Different letters indicates significant differences between nanostructures in each parameter (p < 0.05). 
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curcumin (Fig. 5b and c) when cells were treated with digested NLC and 
NE. In order to understand if the differences observed on viability results 
were influenced by GI fluids, these fluids were also tested. GI fluids had 
no effect on cell viability of digested samples at all concentrations tested 
(Fig. 5d). Furthermore, all excipients presented no cytotoxic effects at 
the highest excipient’s concentration tested (i.e. 3% for the emulsifiers 
and 10% for the lipids) before in vitro digestion (data not shown). 
However, digested MCT oil decreased cell viability when included at a 
level of 8% lipids (Fig. 5e). On the other hand, lecithin and Tween® 80 
did not show cytotoxic effects at all concentrations tested after in vitro 
digestion (Fig. 5f). These results indicate that MCT oil digestion products 
were possibly the responsible for digested NE and NLC cytotoxicity ef-
fects. Other authors also reported that lipid digestion products (such as 
some monoglycerides) at high concentrations (500 μM) were cytotoxic 
to cells (Jia & Wasan, 2008; Sadhukha, Layek, & Prabha, 2018). 
Permeability studies were carried out with non-digested nano-
structures at 25 μg.mL− 1 of curcumin because results showed that these 
nanostructures were not cytotoxic for cells at concentrations below 40 
μg.mL− 1, as previously mentioned. The curcumin Papp values were 
determined for SLN, NLC and NE after 4 h incubation, so that they could 
be compared to other studies. The HPLC chromatograms obtained for 
each nanostructure for different time of incubation were presented in 
the Supplementary file (Figs. 1-3). All samples presented different Papp 
values (p < 0.05) where NLC presented the highest Papp value (6.41 ±
2.26x10-5 cm.s− 1), followed by SLN (1.96 ± 0.47x10-5 cm.s− 1) and NE 
(0.195 ± 0.74x10-5 cm.s− 1). The differences between curcumin Papp 
values for each nanostructure can be explained by their lipid composi-
tion and physical state, since they can influence the curcumin 
Fig. 5. In vitro cytotoxicity of digested curcumin-loaded SLN a), digested curcumin-loaded NLC b), digested curcumin-loaded NE c), GI fluids d), digested and non 
digested MCT oil e) and digested lecithin and digested Tween® 80f) on Caco-2 cells measured by MTS assay. Error bars represent the standard deviation of n = 3 
replications. Different letters indicates significant difference between concentrations for each sample (p < 0.05). * Asterisks indicate significant differences relative to 
the control group (p < 0.05). 
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permeation route, through free compound diffusion or nanostructures 
permeation. Neves et al. (2016) reported that NLC showed a higher 
cellular uptake and permeability than SLN, both with fluorescein iso-
thiocyanate (FITC) incorporated. In order to understand these results, 
the authors analyzed the transepithelial pathways used by each nano-
structure, through the permeability assessment of lucifer yellow and 
propranolol as the paracellular and transcellular tracers, respectively, 
when in contact with the nanostructures. They observed that NLC and 
SLN cross the intestinal barrier predominantly by transcellular route (i.e. 
transcytosis). However, it was observed that NLC were also able to 
permeate the intestinal barrier through paracellular transport, once it 
was observed an increase of the lucifer yellow permeability and a slight 
decrease of the monolayer resistance in the presence of NLC. 
4. Conclusions 
Results demonstrated that lipid-based nanostructures’ physical state 
and composition influenced curcumin’s bioaccessibility, cytotoxicity 
and intestinal permeability. SLN enhanced particle’s stability during in 
vitro digestion and curcumin intestinal permeability; however, they 
presented low curcumin’s bioaccessibility and stability. On the other 
hand, NE showed improved curcumin’s bioaccessibility and stability, 
but lower curcumin intestinal permeability and cytotoxic effects after in 
vitro digestion. NLC showed that the mixture of liquid and solids lipids 
combine the strengths of NE and SLN. NLC exhibit better particle’s 
stability during in vitro digestion and curcumin intestinal permeability 
when compared with NE and higher curcumin’s bioaccessibility when 
compared with SLN. Despite MCT oil is considered a GRAS product, MCT 
oil digestion products presented cytotoxic effects and consequently, 
digested NLC and NE reduced cell viability. These results showed that it 
is essential to evaluate GRAS and bio-based ingredients cytotoxicity 
after in vitro digestion. Therefore, the outcomes of this work have high 
importance to help on selecting ingredients and design lipid-based 
nanostructures as enhanced lipophilic compounds vehicles to be 
applied to food products. 
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